Phase 2 randomized placebo‐controlled study of lasmiditan for the acute treatment of migraine in Japanese patients

OBJECTIVE: To evaluate the efficacy and safety of lasmiditan in Japanese adults with migraine. BACKGROUND: Global clinical studies have demonstrated the efficacy and safety of lasmiditan in the acute treatment of migraine. METHODS: This was a multicenter, randomized, double‐blind, placebo‐controlled...

Description complète

Enregistré dans:
Détails bibliographiques
Publié dans:Headache
Auteurs principaux: Sakai, Fumihiko, Takeshima, Takao, Homma, Gosuke, Tanji, Yuka, Katagiri, Hideaki, Komori, Mika
Format: Artigo
Langue:Inglês
Publié: John Wiley and Sons Inc. 2021
Sujets:
Research Submissions
Accès en ligne:https://ncbi.nlm.nih.gov/pmc/articles/PMC8252620/
https://ncbi.nlm.nih.gov/pubmed/33990951
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/head.14122
Tags: Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!

Documents similaires